Rocket Companies stock drops as bond yields jump — here’s what traders are watching
20 January 2026
2 mins read

Rocket Companies stock drops as bond yields jump — here’s what traders are watching

NEW YORK, January 20, 2026, 12:24 PM ET — Regular session

  • Shares of Rocket Companies dropped roughly 3% amid rising U.S. yields and a sell-off in rate-sensitive stocks.
  • Mortgage lenders have adjusted sharply as bets on the direction of home-loan rates continue to shift.
  • Investors are keeping an eye on Treasury activity and new mortgage rate reports due later this week.

Rocket Companies, Inc. shares dropped 3.3% to $22.47 by midday Tuesday, erasing part of their monthly advance. Rising U.S. bond yields put pressure on housing-related stocks.

Detroit-based mortgage lender faces sharp sensitivity to interest rates. Even slight shifts in home-loan costs can swiftly alter refinancing demand and homebuying activity. As rates climb, potential borrowers tend to hold back, leading to thinner volumes for lenders.

The stock’s slide mirrored a wider risk-off mood. By 11:18 a.m. ET, the Dow had dropped 1.16%, the S&P 500 lost 1.15%, and the Nasdaq slipped 1.34%, as investors absorbed new U.S. tariff threats linked to tensions over Greenland. Jeff Buchbinder, chief equity strategist at LPL Financial, said he expects markets to “settle down” and treat the tough talk as part of bargaining. 1

Bond markets moved swiftly. Long-dated U.S. yields soared following a global selloff Reuters attributed to rising Japanese yields and fresh concerns over fiscal pressures. Seema Shah, chief global strategist at Principal Asset Management, dubbed it a “difficult story about debt.” Kenneth Broux from Societe Generale called the Treasury market’s plight a “perfect storm.” 2

Home-loan rates, which have lingered near multi-year lows, are nudging upward alongside rising yields. The 30-year fixed-rate mortgage hit an average of 6.06% as of January 15, per Freddie Mac’s weekly survey. Meanwhile, NerdWallet reported Tuesday’s rates inching up to roughly 6.1%. 3

Rocket has stood out as a marker for hopes that 2026 could see a more lasting housing recovery if interest rates continue to drop. Earlier this month, the company’s shares surged 6.6% amid a broader sector rally following President Donald Trump’s directive to buy $200 billion in mortgage bonds — these are securities tied to home loans — intended to lower borrowing costs. “Every little bit will help push mortgage yields lower,” Brian Jacobsen, chief economic strategist at Annex Wealth Management, told Reuters then. 4

The housing picture is still uneven. Redfin reported on January 20 that in December, home sellers outpaced buyers by a record margin, signaling a rise in inventory despite ongoing affordability challenges. 5

On Tuesday, other mortgage lenders tumbled with Rocket. UWM Holdings dropped roughly 5.9%, while loanDepot plunged about 11.4% during midday trading.

Homebuilder news is stirring the rate discussion. D.R. Horton beat quarterly estimates but flagged potential margin dips due to rising incentives. RBC analysts highlighted margin pressure and weaker orders as looming concerns. 6

The near-term outlook for Rocket hasn’t changed: rising Treasury yields push mortgage rates up, which slows refinancing and could quickly derail any expected jump in originations. A more stable bond market would work in the opposite direction.

Traders will be eyeing Thursday’s Freddie Mac mortgage-rate update closely, looking to see if the bond market calms down after this week’s wild swings — moves that often shake up rate-sensitive names like Rocket even before any company-specific announcements emerge.

Stock Market Today

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
NEW YORK, Feb 7, 2026, 11:25 AM EST — Market closed. JPMorgan Chase & Co (JPM) shares closed up 3.95% at $322.40 on Friday, giving the biggest U.S. bank a strong finish into the weekend. 1 The move rode a broad rebound in U.S. stocks that pushed the Dow to its first close above 50,000 and lifted the S&P 500 1.97% and the Nasdaq 2.18%. 2 That matters now because the trade has turned less about single-company headlines and more about rates and positioning. “Rotation is the dominant theme this year,” said Angelo Kourkafas, senior global investment strategist at Edward
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
ImmunityBio (IBRX) stock jumps after FDA signals ANKTIVA resubmission path in bladder cancer
Previous Story

ImmunityBio (IBRX) stock jumps after FDA signals ANKTIVA resubmission path in bladder cancer

Mastercard stock slips in regular trading as AI checkout push meets rate-cap jitters
Next Story

Mastercard stock slips in regular trading as AI checkout push meets rate-cap jitters

Go toTop